ANIKA THERAPEUTICS INC (ANIK)
Health Care · NASDAQ
Anika Therapeutics manufactures and markets hyaluronic acid (HA)-based medical products for orthopedic pain management, tissue regeneration, and non-orthopedic surgical applications.
What ANIKA THERAPEUTICS INC does
Anika Therapeutics develops and manufactures hyaluronic acid (HA)-based products for orthopedic and non-orthopedic medical applications. The company's portfolio includes osteoarthritis pain management products (Monovisc, Orthovisc, Cingal), regenerative orthopedic solutions (Integrity Implant System, Tactoset), and non-orthopedic products for ophthalmic and general surgical use. Anika manufactures its HA-based products at its facility in Bedford, Massachusetts and distributes through a combination of direct sales, partnerships with medical device companies like J&J MedTech, and international distributors.
Themes: []
Fundamentals
- Price$16.09 as of 2026-07-09 close
- Market cap$213M as of 2026-07-10
- 1-year return+44.4% as of 2026-07-09 close
- Net margin-9.5% as of 2026-07-10
- Gross margin+58.6% as of 2026-07-10
- ROE-7.7% as of 2026-07-10
- Debt / equity0.00 as of 2026-07-10
- Revenue growth (YoY)-15.4% as of 2026-07-10
- Revenue CAGR (3y)-0.3% SEC XBRL
- Beta0.22 as of 2026-07-10
Key risks (from latest filing)
[]
Fundamentals: Finnhub, as of 2026-07-10. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-09.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date.